Please try another search
In 2024, six companies focused on immunology listed in the US. According to BioPharma Dive data, it was the highest total outside of oncology since 2021 when only seven of 104 newly listed companies...
CAMBRIDGE, UK - The U.S. Food and Drug Administration (FDA) has approved AstraZeneca (NASDAQ:AZN)'s FluMist, a needle-free nasal spray influenza vaccine, for self-administration at home for adults up...
By Khushi Singh and Purvi Agarwal (Reuters) -London's FTSE 100 ended lower on Tuesday, led by a sell-off in healthcare and energy shares, while cooling wage growth in the UK cemented bets for further...
Investing.com -- Shares of AstraZeneca (LON:AZN) dropped on Thursday following the presentation of disappointing final overall survival data from the TROPION-Lung-01 (TL-01) trial at the World...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review